{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T03:32:11Z","timestamp":1781062331196,"version":"3.54.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"7748","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1038\/s41586-019-1007-8","type":"journal-article","created":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T15:08:46Z","timestamp":1552489726000},"page":"399-404","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":367,"title":["Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups"],"prefix":"10.1038","volume":"567","author":[{"given":"Oscar M.","family":"Rueda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen-John","family":"Sammut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A.","family":"Seoane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suet-Feung","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Caswell-Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Callari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajbir","family":"Batra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Bruna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Raza","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Provenzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Parisien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Gillett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"McKinney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leigh","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnie","family":"Purushotham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian O.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D.","family":"Pharoah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Rueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Aparicio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Caldas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,13]]},"reference":[{"key":"1007_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000279","volume":"7","author":"FM Blows","year":"2010","unstructured":"Blows, F. M. et al. Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies. PLoS Med. 7, e1000279 (2010).","journal-title":"PLoS Med."},{"key":"1007_CR2","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S0140-6736(12)61963-1","volume":"381","author":"C Davies","year":"2013","unstructured":"Davies, C. et al. Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. Lancet 381, 805\u2013816 (2013).","journal-title":"Lancet"},{"key":"1007_CR3","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1093\/jnci\/djt244","volume":"105","author":"I Sestak","year":"2013","unstructured":"Sestak, I. et al. Factors predicting late recurrence for estrogen receptor-positive breast cancer. J. Natl Cancer Inst. 105, 1504\u20131511 (2013).","journal-title":"J. Natl Cancer Inst."},{"key":"1007_CR4","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/S1470-2045(13)70387-5","volume":"14","author":"DC Sgroi","year":"2013","unstructured":"Sgroi, D. C. et al. Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population. Lancet Oncol. 14, 1067\u20131076 (2013).","journal-title":"Lancet Oncol."},{"key":"1007_CR5","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1056\/NEJMoa1701830","volume":"377","author":"H Pan","year":"2017","unstructured":"Pan, H. et al. 20-year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years. N. Engl. J. Med. 377, 1836\u20131846 (2017).","journal-title":"N. Engl. J. Med."},{"key":"1007_CR6","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1200\/JCO.2017.76.4258","volume":"36","author":"M Dowsett","year":"2018","unstructured":"Dowsett, M. et al. Integration of clinical variables for the prediction of late distant recurrence in patients with estrogen receptor-positive breast cancer treated with 5 years of endocrine therapy: CTS5. J. Clin. Oncol. 36, 1941\u20131948 (2018).","journal-title":"J. Clin. Oncol."},{"key":"1007_CR7","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1200\/JCO.2015.65.2289","volume":"34","author":"LN Harris","year":"2016","unstructured":"Harris, L. N. et al. Use of biomarkers to guide decisions on adjuvant systemic therapy for women with early-stage invasive breast cancer: American Society of Clinical Oncology clinical practice guideline. J. Clin. Oncol. 34, 1134\u20131150 (2016).","journal-title":"J. Clin. Oncol."},{"key":"1007_CR8","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1200\/JCO.2014.55.4139","volume":"32","author":"GW Sledge","year":"2014","unstructured":"Sledge, G. W. et al. Past, present, and future challenges in breast cancer treatment. J. Clin. Oncol. 32, 1979\u20131986 (2014).","journal-title":"J. Clin. Oncol."},{"key":"1007_CR9","doi-asserted-by":"publisher","unstructured":"Richman, J. & Dowsett, M. Beyond 5 years: enduring risk of recurrence in oestrogen receptor-positive breast cancer. Nat. Rev. Clin. Oncol. 1, \n                    https:\/\/doi.org\/10.1038\/s41571-018-0145-5\n                    \n                   (2018).","DOI":"10.1038\/s41571-018-0145-5"},{"key":"1007_CR10","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou, C. M. et al. Molecular portraits of human breast tumours. Nature 406, 747\u2013752 (2000).","journal-title":"Nature"},{"key":"1007_CR11","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1200\/JCO.2008.18.1370","volume":"27","author":"JS Parker","year":"2009","unstructured":"Parker, J. S. et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. J. Clin. Oncol. 27, 1160\u20131167 (2009).","journal-title":"J. Clin. Oncol."},{"key":"1007_CR12","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature10983","volume":"486","author":"C Curtis","year":"2012","unstructured":"Curtis, C. et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486, 346\u2013352 (2012).","journal-title":"Nature"},{"key":"1007_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0431-1","volume":"15","author":"HR Ali","year":"2014","unstructured":"Ali, H. R. et al. Genome-driven integrated classification of breast cancer validated in over 7,500 samples. Genome Biol. 15, 431 (2014).","journal-title":"Genome Biol."},{"key":"1007_CR14","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/bimj.200510218","volume":"48","author":"H Putter","year":"2006","unstructured":"Putter, H., van der Hage, J., de Bock, G. H., Elgalta, R. & van de Velde, C. J. H. Estimation and prediction in a multi-state model for breast cancer. Biom. J. 48, 366\u2013380 (2006).","journal-title":"Biom. J."},{"key":"1007_CR15","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0140-6736(91)90475-5","volume":"338","author":"B Fisher","year":"1991","unstructured":"Fisher, B. et al. Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet 338, 327\u2013331 (1991).","journal-title":"Lancet"},{"key":"1007_CR16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1023\/A:1006285726561","volume":"56","author":"A Insa","year":"1999","unstructured":"Insa, A. et al. Prognostic factors predicting survival from first recurrence in patients with metastatic breast cancer: analysis of 439 patients. Breast Cancer Res. Treat. 56, 67\u201378 (1999).","journal-title":"Breast Cancer Res. Treat."},{"key":"1007_CR17","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1002\/sim.2712","volume":"26","author":"H Putter","year":"2007","unstructured":"Putter, H., Fiocco, M. & Geskus, R. B. Tutorial in biostatistics: competing risks and multi-state models. Stat. Med. 26, 2389\u20132430 (2007).","journal-title":"Stat. Med."},{"key":"1007_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2464","volume":"12","author":"GC Wishart","year":"2010","unstructured":"Wishart, G. C. et al. PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer. Breast Cancer Res. 12, R1 (2010); erratum 12, 401 (2010).","journal-title":"Breast Cancer Res."},{"key":"1007_CR19","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s10549-011-1366-9","volume":"128","author":"JS Michaelson","year":"2011","unstructured":"Michaelson, J. S. et al. Improved web-based calculators for predicting breast carcinoma outcomes. Breast Cancer Res. Treat. 128, 827\u2013835 (2011).","journal-title":"Breast Cancer Res. Treat."},{"key":"1007_CR20","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1023\/A:1023033708204","volume":"78","author":"CJ Ormandy","year":"2003","unstructured":"Ormandy, C. J., Musgrove, E. A., Hui, R., Daly, R. J. & Sutherland, R. L. Cyclin D1, EMS1 and 11q13 amplification in breast cancer. Breast Cancer Res. Treat. 78, 323\u2013335 (2003).","journal-title":"Breast Cancer Res. Treat."},{"key":"1007_CR21","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/j.cell.2014.10.048","volume":"159","author":"F Sanchez-Garcia","year":"2014","unstructured":"Sanchez-Garcia, F. et al. Integration of genomic data enables selective discovery of breast cancer drivers. Cell 159, 1461\u20131475 (2014).","journal-title":"Cell"},{"key":"1007_CR22","doi-asserted-by":"publisher","first-page":"3397","DOI":"10.1038\/onc.2011.515","volume":"31","author":"Y Shrestha","year":"2012","unstructured":"Shrestha, Y. et al. PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signaling. Oncogene 31, 3397\u20133408 (2012).","journal-title":"Oncogene"},{"key":"1007_CR23","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/emmm.201100122","volume":"3","author":"DG Holland","year":"2011","unstructured":"Holland, D. G. et al. ZNF703 is a common luminal B breast cancer oncogene that differentially regulates luminal and basal progenitors in human mammary epithelium. EMBO Mol. Med. 3, 167\u2013180 (2011).","journal-title":"EMBO Mol. Med."},{"key":"1007_CR24","doi-asserted-by":"publisher","first-page":"6652","DOI":"10.1158\/1078-0432.CCR-06-1164","volume":"12","author":"JS Reis-Filho","year":"2006","unstructured":"Reis-Filho, J. S. et al. FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas. Clin. Cancer Res. 12, 6652\u20136662 (2006).","journal-title":"Clin. Cancer Res."},{"key":"1007_CR25","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1016\/j.celrep.2017.02.022","volume":"18","author":"H Liu","year":"2017","unstructured":"Liu, H. et al. Pharmacologic targeting of S6K1 in PTEN-deficient neoplasia. Cell Reports 18, 2088\u20132095 (2017).","journal-title":"Cell Reports"},{"key":"1007_CR26","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.cell.2011.08.017","volume":"146","author":"JE Delmore","year":"2011","unstructured":"Delmore, J. E. et al. BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 146, 904\u2013917 (2011).","journal-title":"Cell"},{"key":"1007_CR27","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1158\/2159-8290.CD-15-1246","volume":"6","author":"A Pearson","year":"2016","unstructured":"Pearson, A. et al. High-level clonal FGFR amplification and response to FGFR inhibition in a translational clinical trial. Cancer Discov. 6, 838\u2013851 (2016).","journal-title":"Cancer Discov."},{"key":"1007_CR28","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3816\/CBC.2008.n.035","volume":"8","author":"IL Wapnir","year":"2008","unstructured":"Wapnir, I. L. et al. A randomized clinical trial of adjuvant chemotherapy for radically resected locoregional relapse of breast cancer: IBCSG 27-02, BIG 1-02, and NSABP B-37. Clin. Breast Cancer 8, 287\u2013292 (2008).","journal-title":"Clin. Breast Cancer"},{"key":"1007_CR29","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1200\/JCO.1987.5.1.55","volume":"5","author":"GM Clark","year":"1987","unstructured":"Clark, G. M., Sledge, G. W. Jr, Osborne, C. K. & McGuire, W. L. Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients. J. Clin. Oncol. 5, 55\u201361 (1987).","journal-title":"J. Clin. Oncol."},{"key":"1007_CR30","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1200\/JCO.2009.25.9820","volume":"28","author":"H Kennecke","year":"2010","unstructured":"Kennecke, H. et al. Metastatic behavior of breast cancer subtypes. J. Clin. Oncol. 28, 3271\u20133277 (2010).","journal-title":"J. Clin. Oncol."},{"key":"1007_CR31","first-page":"205","volume":"23","author":"E Fix","year":"1951","unstructured":"Fix, E. & Neyman, J. A simple stochastic model of recovery, relapse, death and loss of patients. Hum. Biol. 23, 205\u2013241 (1951).","journal-title":"Hum. Biol."},{"key":"1007_CR32","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1023\/A:1006197524405","volume":"54","author":"P Bro\u00ebt","year":"1999","unstructured":"Bro\u00ebt, P. et al. Analyzing prognostic factors in breast cancer using a multistate model. Breast Cancer Res. Treat. 54, 83\u201389 (1999).","journal-title":"Breast Cancer Res. Treat."},{"key":"1007_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-13-80","volume":"13","author":"C Meier-Hirmer","year":"2013","unstructured":"Meier-Hirmer, C. & Schumacher, M. Multi-state model for studying an intermediate event using time-dependent covariates: application to breast cancer. BMC Med. Res. Methodol. 13, 80 (2013).","journal-title":"BMC Med. Res. Methodol."},{"key":"1007_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-3294-8","volume-title":"Modeling Survival Data: Extending the Cox Model","author":"TM Therneau","year":"2000","unstructured":"Therneau, T. M. & Grambsch, P. M. Modeling Survival Data: Extending the Cox Model (Springer, New York, 2000)."},{"key":"1007_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v038.i07","volume":"38","author":"LC Wreede de","year":"2011","unstructured":"de Wreede, L. C., Fiocco, M. & Putter, H. mstate: an R package for the analysis of competing risks and multi-state models. J. Stat. Software 38, 1\u201330 (2011).","journal-title":"J. Stat. Software"},{"key":"1007_CR36","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1002\/sim.4780122408","volume":"12","author":"JP Klein","year":"1993","unstructured":"Klein, J. P., Keiding, N. & Copelan, E. A. Plotting summary predictions in multistate survival models: probabilities of relapse and death in remission for bone marrow transplantation patients. Stat. Med. 12, 2315\u20132332 (1993).","journal-title":"Stat. Med."},{"key":"1007_CR37","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-68560-1","volume-title":"Survival and Event History Analysis\u2014A Process Point of View","author":"O Aalen","year":"2008","unstructured":"Aalen, O., Borgan, O. & Gjessing, H. Survival and Event History Analysis\u2014A Process Point of View (Springer, New York, 2008)."},{"key":"1007_CR38","doi-asserted-by":"publisher","first-page":"4340","DOI":"10.1002\/sim.3305","volume":"27","author":"M Fiocco","year":"2008","unstructured":"Fiocco, M., Putter, H. & van Houwelingen, H. C. Reduced-rank proportional hazards regression and simulation-based prediction for multi-state models. Stat. Med. 27, 4340\u20134358 (2008).","journal-title":"Stat. Med."},{"key":"1007_CR39","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/bimj.200810425","volume":"50","author":"T Hothorn","year":"2008","unstructured":"Hothorn, T., Bretz, F. & Westfall, P. Simultaneous inference in general parametric models. Biom. J. 50, 346\u2013363 (2008).","journal-title":"Biom. J."},{"key":"1007_CR40","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1080\/01621459.1955.10501294","volume":"50","author":"CW Dunnett","year":"1955","unstructured":"Dunnett, C. W. A multiple comparison procedure for comparing several treatments with a control. J. Am. Stat. Assoc. 50, 1096\u20131121 (1955).","journal-title":"J. Am. Stat. Assoc."},{"key":"1007_CR41","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/biomet\/68.2.373","volume":"68","author":"RL Prentice","year":"1981","unstructured":"Prentice, R. L., Williams, B. J. & Peterson, A. V. On the regression analysis of multivariate failure time data. Biometrika 68, 373\u2013379 (1981).","journal-title":"Biometrika"},{"key":"1007_CR42","doi-asserted-by":"crossref","unstructured":"Harrell, F. E. J. Regression Modeling Strategies (Springer, 2001).","DOI":"10.1007\/978-1-4757-3462-1"},{"key":"1007_CR43","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nm.2090","volume":"16","author":"Y Li","year":"2010","unstructured":"Li, Y. et al. Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer. Nat. Med. 16, 214\u2013218 (2010).","journal-title":"Nat. Med."},{"key":"1007_CR44","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1093\/carcin\/bgt208","volume":"34","author":"C Clarke","year":"2013","unstructured":"Clarke, C. et al. Correlating transcriptional networks to breast cancer survival: a large-scale coexpression analysis. Carcinogenesis 34, 2300\u20132308 (2013).","journal-title":"Carcinogenesis"},{"key":"1007_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-9-239","volume":"9","author":"S Loi","year":"2008","unstructured":"Loi, S. et al. Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen. BMC Genomics 9, 239 (2008).","journal-title":"BMC Genomics"},{"key":"1007_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2013-14-4-r34","volume":"14","author":"S Nagalla","year":"2013","unstructured":"Nagalla, S. et al. Interactions between immunity, proliferation and molecular subtype in breast cancer prognosis. Genome Biol. 14, R34 (2013).","journal-title":"Genome Biol."},{"key":"1007_CR47","doi-asserted-by":"publisher","first-page":"5405","DOI":"10.1158\/0008-5472.CAN-07-5206","volume":"68","author":"M Schmidt","year":"2008","unstructured":"Schmidt, M. et al. The humoral immune system has a key prognostic impact in node-negative breast cancer. Cancer Res. 68, 5405\u20135413 (2008).","journal-title":"Cancer Res."},{"key":"1007_CR48","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1158\/1078-0432.CCR-06-2765","volume":"13","author":"C Desmedt","year":"2007","unstructured":"Desmedt, C. et al. Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series. Clin. Cancer Res. 13, 3207\u20133214 (2007).","journal-title":"Clin. Cancer Res."},{"key":"1007_CR49","doi-asserted-by":"publisher","first-page":"13550","DOI":"10.1073\/pnas.0506230102","volume":"102","author":"LD Miller","year":"2005","unstructured":"Miller, L. D. et al. An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc. Natl Acad. Sci. USA 102, 13550\u201313555 (2005); correction 102, 17882 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1007_CR50","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","volume":"20","author":"L Gautier","year":"2004","unstructured":"Gautier, L., Cope, L., Bolstad, B. M. & Irizarry, R. A. affy\u2014analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20, 307\u2013315 (2004).","journal-title":"Bioinformatics"},{"key":"1007_CR51","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","volume":"28","author":"JT Leek","year":"2012","unstructured":"Leek, J. T., Johnson, W. E., Parker, H. S., Jaffe, A. E. & Storey, J. D. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics 28, 882\u2013883 (2012).","journal-title":"Bioinformatics"},{"key":"1007_CR52","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1093\/bioinformatics\/btv693","volume":"32","author":"DMA Gendoo","year":"2016","unstructured":"Gendoo, D. M. A. et al. Genefu: an R\/Bioconductor package for computation of gene expression-based signatures in breast cancer. Bioinformatics 32, 1097\u20131099 (2016).","journal-title":"Bioinformatics"},{"key":"1007_CR53","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.1093\/bioinformatics\/btr511","volume":"27","author":"MS Schr\u00f6der","year":"2011","unstructured":"Schr\u00f6der, M. S., Culhane, A. C., Quackenbush, J. & Haibe-Kains, B. survcomp: an R\/Bioconductor package for performance assessment and comparison of survival models. Bioinformatics 27, 3206\u20133208 (2011).","journal-title":"Bioinformatics"},{"key":"1007_CR54","unstructured":"R Core Team. \u00a0R: A Language and Environment for Statistical Computing. \n                    http:\/\/www.r-project.org\/\n                    \n                   (2015)."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41586-019-1007-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41586-019-1007-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41586-019-1007-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:53:43Z","timestamp":1684605223000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-019-1007-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":54,"journal-issue":{"issue":"7748","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["1007"],"URL":"https:\/\/doi.org\/10.1038\/s41586-019-1007-8","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.735311249.793558235","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"4 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.A. is founder and shareholder of Contextual Genomic and a scientific advisor to Sangamo Biosciences and Takeda Pharmaceuticals. C. Caldas is a scientific advisor to AstraZeneca-iMed and has received research funding from AstraZeneca, Servier and Genentech\/Roche. C.\u00a0Curtis is a scientific advisory board member and shareholder of GRAIL and consultant for GRAIL and Genentech. A patent application has been filed on aspects of the described work, entitled \u2018Methods of treatment based upon molecular characterization of breast cancer\u2019 (C.\u00a0Curtis,\u00a0C. Caldas, J.A.S. and O.M.R.).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}